5:41 PM
 | 
Nov 08, 2012
 |  BC Extra  |  Company News

Sun to acquire DUSA

Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA) will acquire dermatology company DUSA Pharmaceuticals Inc. (NASDAQ:DUSA) for $8 per share in cash, or about $230 million....

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >